CANTANHEDE, Portugal, Oct. 16, 2023 Tilray Medical, a division of Tilray Brands, Inc. and a global leader in medical cannabis, empowering the therapeutic alliance between patients and.
On Monday, Tilray Medical, a division of Tilray Brands, Inc. (NASDAQ: TLRY) (TSX: TLRY), announced its contribution to an independent clinical trial to research the efficacy of medical cannabis as a treatment for glioblastoma, which is a seve
A targeted therapy has more than doubled progression-free survival of patients with gliomas a disease that killed Spanish golf player Severiano Ballesteros
E-Mail
IMAGE: Signature of RENACER bylaws. From left to right and from top to bottom: Manuel Valiente (CNIO), Eva Ortega-Paíno (CNIO), Pilar Nicolás (ISCIII), Ángel Pérez (12 de Octubre Hospital), Elena Martínez. view more
Credit: CNIO
Last January 25th, the bylaws of the National Brain Metastasis Network (or RENACER, its acronym in Spanish) were signed and the network s first meeting was held. To date, 11 Spanish hospitals have joined the network to create a collection of human samples to further research into brain metastases, to improve both their diagnosis and treatment. Through this project, initiated and coordinated by the Brain Metastasis Group and the Biobank of the Spanish National Cancer Research Centre (CNIO), samples from the member hospitals will be collected and stored.